| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Advanced Microbubbles |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Bayer |
| Recipient: You |
| Company: AI Therapeutics |
| Recipient: You |
| Company: Jazz Pharmaceuticals |
| Recipient: You |
| Company: ITM Oncologics |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Turning Point Therapeutics |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Roche/Genentech |
| Recipient: Your Institution |
| Company: Taiho Oncology |
| Recipient: Your Institution |
| Company: Advanced Accelerator Applications/Novartis |
| Recipient: Your Institution |
| Company: BioAtla |
| Recipient: Your Institution |
| Company: Hoffmann-LaRoche |
| Recipient: Your Institution |
| Company: Jazz Pharmaceuticals |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Adaptimmune |
| Recipient: Your Institution |
| Company: ITM Oncologics |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|